Top compounds associated with response to LRRC61


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.002
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.12 0.002
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.18 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA pac-1 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.11 0.003
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.11 0.004
Download CSV